Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Omobonike Oloruntoba"'
Publikováno v:
Clin Liver Dis (Hoboken)
Content available: Author Audio Recording.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23928eba4aacf8cf26b3c88cc794ab9
https://europepmc.org/articles/PMC8549717/
https://europepmc.org/articles/PMC8549717/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of hospital medicine. 16(12)
Autor:
Nicole E. Rich, Reena Salgia, Janice H. Jou, Ruben Hernaez, Amit G. Singal, Neil Mehta, Christina C. Lindenmeyer, Andres Duarte-Rojo, Whitney E. Jackson, Avegail Flores, George N. Ioannou, Ponni V. Perumalswami, Sofia Kagan, Steven Scaglione, Sheila Eswaran, Hrishikesh Samant, Renumathy Dhanasekaran, Oren K. Fix, Shaun Chandna, Laura Kulik, Anjana Pillai, Jorge A. Marrero, Adnan Said, Sanjaya K. Satapathy, Maarouf Hoteit, Prasun K. Jalal, Elizabeth X. Zheng, Naim Alkhouri, Catherine Frenette, Russell Rosenblatt, Nayan M. Patel, Devika Kapuria, Z. Gordon Jiang, Amol S. Rangnekar, Ju Dong Yang, Neehar D. Parikh, Omobonike Oloruntoba, Binu John, Parvez S. Mantry, Veeral Ajmera, Mina Rakoski, James Hanje, Andrew M. Moon, Mobolaji Odewole, Michael D. Leise, Nyan L. Latt, Robert J. Wong
Publikováno v:
Clin Gastroenterol Hepatol
Background & Aims Direct-acting antivirals (DAAs) are effective against hepatitis C virus and sustained virologic response is associated with reduced incidence of hepatocellular carcinoma (HCC). However, there is controversy over the use of DAAs in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15b6475f93447f0368531c75532c44b8
Autor:
Omobonike Oloruntoba, Andrew J. Muir
Publikováno v:
Current Treatment Options in Infectious Diseases. 10:330-336
With the recent introduction of direct acting antiviral agents for hepatitis C treatment, many patients are receiving these highly effective therapies. Patients with advanced fibrosis or cirrhosis prior to antiviral treatment will have decreased but
Autor:
Caitlin C. Murphy, Robert J. Wong, Neil Mehta, Jordan J. Feld, Andrea D. Branch, Annsa Huang, Meher Sindhoora Mavuram, Prasun K. Jalal, Nicole E. Rich, Laura Kulik, Jennifer Guy, Parvez S. Mantry, Avegail Flores, Chanda Ho, Sasank Nakka, Amit G. Singal, Mobolaji Odewole, Hrishikesh Samant, Renumathy Dhanasekaran, Amol S. Rangnekar, Usman Rahim, Maarouf Hoteit, Omobonike Oloruntoba, Michael D. Leise, Tram Tran, Neehar D. Parikh, Sanjaya K. Satapathy, Venkata Rajesh Konjeti, Kalyan Ram Bhamidimarri, Wassim Noureddine, Sheila Eswaran, Catherine Frenette, Adnan Said, Steven J. Scaglione, Robert Mitrani, Andres Duarte-Rojo, Kevin Nelson, Janice H. Jou, Michael L. Volk, Alexander Dao, Anjana Pillai, Binu John, Jesse J. Xie, Myron Schwartz, Kelly Delarosa, Reena Salgia, Suresh Misra
Publikováno v:
Gastroenterology, vol 156, iss 6
Gastroenterology
Gastroenterology
Background & Aims There is controversy over the effects of direct-acting antiviral (DAA) therapies for hepatitis C virus (HCV) infection on hepatocellular carcinoma (HCC) recurrence and tumor aggressiveness. We compared HCC recurrence patterns betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce97389838c7d5851403de16b34b8358
https://escholarship.org/uc/item/34r886zm
https://escholarship.org/uc/item/34r886zm
Publikováno v:
Clinical Liver Disease. 7:1-4
Publikováno v:
Hepatology. 68:2424-2425
Women with cirrhosis awaiting liver transplantation (LT) experience higher rates of waitlist mortality than men; it is unknown whether practices surrounding delisting for being “too sick” for LT contribute to this disparity beyond death alone. We
Autor:
Caitlin C. Murphy, Andres Duarte-Rojo, Reena Salgia, Omobonike Oloruntoba, Annsa Huang, Sofia Kagan, Michael D. Leise, Jordan J. Feld, Parvez S. Mantry, Purva Gopal, Hrishikesh Samant, Neil Mehta, Renumathy Dhanasekaran, Adnan Said, Laura Kulik, Sheila Eswaran, Steven Scaglione, Jennifer Guy, Binu John, Anjana Pillai, Kalyan Ram Bhamidimarri, Michael L. Volk, Andrea D. Branch, Janice H. Jou, Prasun K. Jalal, Maarouf Hoteit, Catherine Frenette, Robert J. Wong, Mobolaji Odewole, Amit G. Singal, Amol S. Rangnekar, George N. Ioannou, Neehar D. Parikh, Nicole E. Rich, Avegail Flores, Tram Tran, Sanjaya K. Satapathy
Publikováno v:
Gastroenterology, vol 157, iss 5
Background & Aims There is controversy regarding the benefits of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection for patients with a history of hepatocellular carcinoma (HCC). We performed a multicenter cohort study to com
Autor:
Angela Whatley, Cathy M. St. Pierre, Scott L. DuVall, Omobonike Oloruntoba, Julie Lynch, Brygida Berse, Christine M. Hunt
Publikováno v:
Military medicine. 181(10)
We assessed implementation of precision medicine within the Veterans Health Administration. We analyzed the use of interleukin-28B (IL28B) pharmacogenetic test, which predicts interferon-α treatment response in patients with hepatitis C. Patients wi